This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Groves, A. M.M. Articles by Rosenthal, E. Search for Related Content PubMed PubMed Citation Articles by Groves, A. M.M. Articles by Rosenthal, E. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information High Risk Pregnancy

(Circulation. 1995;92:3394-3396.)
© 1995 American Heart Association, Inc.

Articles

Therapeutic Trial of Sympathomimetics in Three Cases of Complete Heart Block in the Fetus

Alison M.M. Groves, BSc, MB BS, MRCP; Lindsey D. Allan, MD, FRCP; Eric Rosenthal, MD, MRCP

From the Departments of Fetal and Paediatric Cardiology, Guy's Hospital, London.

Correspondence to Dr A. Groves, 15th Floor, Guy's Tower, St Thomas's St, London SE1 9RT, England.

Background A total of 36 fetuses with isolated congenital complete heart block and structurally normal hearts have been seen in the department of fetal echocardiography since 1980. Although the prognosis is good in the majority of cases, those who develop intrauterine cardiac failure have a high mortality. The aim of this study was to investigate the contribution to management of sympathomimetic therapy by comparing two possible agents administered to the mothers.

Methods and Results The effect of two sympathomimetic agents, isoprenaline and salbutamol, was compared in three patients with isolated complete heart block. Fetal heart rate and indexes of cardiac function were monitored during therapy. Maternal cardiovascular status was also regularly assessed. Dosage of isoprenaline increased from 1 to 12 µg/min, and salbutamol increased from 4 to 64 µg/min during the trial. No significant change was detected with isoprenaline therapy, but all fetuses showed an increase in heart rate and improvement in ventricular function with salbutamol. Salbutamol was maintained until delivery in one case with evidence of cardiac failure, with resolution of fetal hydrops. All three delivered in good condition close to term. Two of three required pacing in the neonatal period.

Conclusions We conclude that salbutamol can be effective in the treatment of fetal complete heart block and should be considered in patients with this condition where there is evidence of deteriorating cardiac function.

Key Words: heart block • drugs, sympathomimetic • fetus

This article has been cited by other articles:

				A. C. Glatz, J. W. Gaynor, L. A. Rhodes, J. Rychik, R. E. Tanel, V. L. Vetter, J. R. Kaltman, S. C. Nicolson, L. Montenegro, and M. J. Shah Outcome of high-risk neonates with congenital complete heart block paced in the first 24 hours after birth J. Thorac. Cardiovasc. Surg., September 1, 2008; 136(3): 767 - 773. [Abstract] [Full Text] [PDF]

				J. Frankovich, C. Sandborg, P. Barnes, S. Hintz, and E. Chakravarty Neonatal Lupus and Related Autoimmune Disorders of Infants NeoReviews, May 1, 2008; 9(5): e206 - e217. [Abstract] [Full Text] [PDF]

				P.A. Gordon Review: Congenital heart block: clinical features and therapeutic approaches Lupus, August 1, 2007; 16(8): 642 - 646. [Abstract] [PDF]

				Y Maeno, W Himeno, A Saito, S Hiraishi, O Hirose, M Ikuma, N Inamura, M Kawataki, A Mizukami, M Ota, et al. Clinical course of fetal congenital atrioventricular block in the Japanese population: a multicentre experience Heart, August 1, 2005; 91(8): 1075 - 1079. [Abstract] [Full Text] [PDF]

				E. Rosenthal, P. A. Gordon, J. M. Simpson, G. K. Sharland, E. T. Jaeggi, J. Smallhorn, E. D. Silverman, J.-C. Fouron, G. Ryan, and L. K. Hornberger Letter Regarding Article by Jaeggi et al, "Transplacental Fetal Treatment Improves the Outcome of Prenatally Diagnosed Complete Atrioventricular Block Without Structural Heart Disease" * Response Circulation, May 10, 2005; 111(18): e287 - e288. [Full Text] [PDF]

				E. T. Jaeggi, J.-C. Fouron, E. D. Silverman, G. Ryan, J. Smallhorn, and L. K. Hornberger Transplacental Fetal Treatment Improves the Outcome of Prenatally Diagnosed Complete Atrioventricular Block Without Structural Heart Disease Circulation, September 21, 2004; 110(12): 1542 - 1548. [Abstract] [Full Text] [PDF]

				A Brucato, A Jonzon, D Friedman, L D Allan, G Vignati, M Gasparini, J I Stein, S Montella, M Michaelsson, and J Buyon Proposal for a new definition of congenital complete atrioventricular block Lupus, June 1, 2003; 12(6): 427 - 435. [Abstract] [PDF]

				S. R.F.F. Pedra, J. F. Smallhorn, G. Ryan, D. Chitayat, G. P. Taylor, R. Khan, M. Abdolell, and L. K. Hornberger Fetal Cardiomyopathies: Pathogenic Mechanisms, Hemodynamic Findings, and Clinical Outcome Circulation, July 30, 2002; 106(5): 585 - 591. [Abstract] [Full Text] [PDF]

				E. T. Jaeggi, R. M. Hamilton, E. D. Silverman, S. A. Zamora, and L. K. Hornberger Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block: A single institution's experience of 30 years J. Am. Coll. Cardiol., January 2, 2002; 39(1): 130 - 137. [Abstract] [Full Text] [PDF]